SCHEMBL14415228

SCHEMBL14415228

C=CCc1cccc(C(=O)OC(C)(C)C)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 0.59
CYP3A4 P08684 3/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
LOXL2 Q9Y4K0 1/20 0.45
CYP4F2 P78329 3/20 0.44
CYP4A11 Q02928 3/20 0.44
PTGS2 P35354 1/20 0.43
CYP2C19 P33261 1/20 0.41
PTGS1 P23219 2/20 0.40
ELANE P08246 1/20 0.40
MRGPRX4 Q96LA9 1/20 0.39
STAT3 P40763 1/20 0.39
PPARA Q07869 1/20 0.39
ALDH1A1 P00352 3/20 0.39
ALOX5 P09917 1/20 0.39
AR P10275 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL757447 0.84 LOXL2 (0.64) SLC7A5CYP3A4MEN1KMT2ATDP1
SCHEMBL10431445 0.84 SLC7A5 (0.62) SLC7A5LOXL2CYP4F2CYP4A11MRGPRX4
SCHEMBL12301533 0.84 SLC7A5 (0.65) SLC7A5LOXL2CYP4F2CYP4A11CYP2C19
SCHEMBL3499880 0.83 SLC7A5 (0.63) SLC7A5LOXL2CYP4F2CYP4A11MRGPRX4
SCHEMBL7384982 0.83 SLC7A5 (0.63) SLC7A5TDP1LOXL2CYP4F2CYP4A11
SCHEMBL3293258 0.82 CYP4F2 (0.61) CYP3A4MEN1KMT2ATDP1L3MBTL1
SCHEMBL28813161 0.81 MEN1 (0.48) SLC7A5CYP3A4MEN1KMT2ATDP1
SCHEMBL4928282 0.81 LOXL2 (0.69) SLC7A5LOXL2CYP4F2CYP4A11MRGPRX4
SCHEMBL22019046 0.81 SLC7A5 (0.62) SLC7A5TDP1LOXL2CYP4F2CYP4A11
SCHEMBL127411 0.81 SLC7A5 (0.62) SLC7A5LOXL2CYP4F2CYP4A11CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070225303-A1 8-Oxoadenine Compound DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-09-27 US disclosed
US-20070225303-A1 8-Oxoadenine Compound DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225303-A1 8-Oxoadenine Compound TLR7, CCR8, TLR8 SLC7A5 520/4885CYP3A4 1622/4885MEN1 3974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.